Report: VC funding for European biotech is gaining strength

08/8/2013 | Reuters

Venture capital investment in the European biotech industry continues to gain momentum, according to a BioWorld Snapshots report. Private biotech firms globally secured nearly $1.3 billion in venture capital funding in the second quarter of 2013, up 190% from the previous quarter. European firms accounted for 44% of deals. "Maybe you could describe the U.S. market as a tsunami and Europe as a rising tide, but it's growing and it's growing steadily," analyst Jim Healy said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC